MCI — Medcaw Investments Cashflow Statement
0.000.00%
- £0.69m
- £0.52m
Annual cashflow statement for Medcaw Investments, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -0.066 | -0.194 | -0.712 |
Non-Cash Items | — | 0.009 | 0.173 |
Other Non-Cash Items | |||
Changes in Working Capital | 0.032 | 0.153 | -0.147 |
Change in Accounts Receivable | |||
Change in Accounts Payable | |||
Change in Payable / Accrued Expenses | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -0.034 | -0.032 | -0.686 |
Other Investing Cash Flow Items | — | — | -0.149 |
Other Investing Cash Flow | |||
Cash from Investing Activities | — | — | -0.149 |
Financing Cash Flow Items | -0.005 | 0 | — |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Cash from Financing Activities | 0.235 | 0.475 | 0.563 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.201 | 0.443 | -0.272 |